IP Cases — 2006
55 decisions across all jurisdictions
Page 2 of 2 · 55 total
Intel Corporation v.Anil Hada And Ors.
Intel Corporation sought an interim injunction against defendants using 'INTEL' in their corporate names, citing trademark infringement and dilution. The Delhi High Court ultimately dismissed the applications for interim relief, finding that there was no prima facie evidence of dishonest adoption by the defendants. The court noted the significant delay in filing suit (over 15 years) and balanced this against the defendants' established reputation, leaning the balance of convenience in their favor.
Novartis Ag. v.Cipla Ltd.
Cipla Ltd. opposed Novartis AG's patent application for a new crystal form of imatinib mesylate. The IPAB found that the subject matter was merely a new form of a known substance without significant enhancement in efficacy, thus failing Section 3(d). Furthermore, the court disqualified the application due to improper claiming of Swiss priority.
Novartis Ag v.Cancer Patients Aid Association.
The opposition was filed against Novartis AG's patent application for a specific crystalline form (ß-crystal) of imatinib mesylate. The Tribunal found that the invention was anticipated by prior art and did not meet the enhanced efficacy requirement under Section 3(d), leading to the refusal of the patent application.
Bentec Electricals And Electronics v.Bentex Control And Switchgear Co.
The dispute concerned an opposition filed by Bentex Control & Switchgear Co. against a trademark application for 'BENTEC'. The core issue was whether the notice of opposition and the request for extension were within the statutory time limits, given delays in receiving the Trade Marks Journal.
Garware-Wall Ropes Ltd. v.Mr. Anant Kanoi And Ors.
Garware-Wall Ropes Ltd. sued M/s Techfab India (Defendant No. 1) alleging infringement of their patent for a synthetic rope gabion and sought permanent injunction and damages. The defendants argued that the invention was prior art and should be revoked under Section 64 of the Patents Act, 1970.
Mr. Ravi Raj Khanna And Anr. v.Mr. Lalit Gupta And Anr.
The plaintiffs filed a suit seeking permanent and mandatory injunction for passing off and infringement of their designer furniture. The defendants challenged the interim orders by arguing that the plaintiff's designs were already in public domain prior to registration, thus defeating protection under the Designs Act, 2000.
Dr. Anji Reddy (Appellant) v.Hoechst Aktiengesellschaft
The Madras High Court allowed an appeal filed by Hoechst Aktiengesellschaft against a single judge's decision, restoring the original trademark registration order. The dispute centered on whether the mark 'Novigan,' applied for in Class 5 (pharmaceutical preparations), was deceptively similar to the existing registered mark 'Novalgin.' The court found that despite structural similarities, the marks were phonetically and visually distinct enough not to cause confusion among the general public. This ruling emphasizes deference to technical authorities like the Assistant Registrar when assessing trademark similarity.
Amanat Tobacco Gul Manufacture v.Aftab Tobacco Products
The matter involved a Review Petition filed by Amanat Tobacco Gul Manufacture against an order that abandoned Opposition No. DEL-T-3769 regarding the registration of the trade mark 'Raja Gul Label' sought by Aftab Tobacco Products. The petitioners argued that their evidence was not considered and procedural lapses occurred, but the Tribunal found no error apparent on the face of the record.
Jcb India Ltd. v.Commissioner Of Service Tax
Jcb India Ltd. appealed an order from the Commissioner of Service Tax demanding significant amounts of service tax and penalties, arguing that the transaction was a transfer of technical know-how, not a rendering of services. The Tribunal examined the agreement which granted a license under patents and know-how for manufacturing licensed products.
Tractors And Farm Equipment Ltd. v.Green Field Farm Equipments Pvt. Ltd.
The plaintiff filed two Original Applications seeking interim injunctions against the respondents. O.A. No. 18 sought to restrain the manufacture and sale of tractors (like Maharaja 3300) that substantially imitated the plaintiff's Hunter Tractor design, while O.A. No. 19 aimed to prevent the exploitation of confidential information and technical data related to the Hunter tractor project. The court found prima facie evidence of copyright infringement and breach of confidentiality in favor of the plaintiff.
Hyderabad Chemical Supplies Limited v.United Phosphorus Limited And Anr.
The petitioner filed an Original Petition seeking revocation and interim suspension of Patent No. 185229. The respondent argued that since a related suit was already pending before the District Court, Indore, and a restraint order had been obtained there, conflicting orders could not be passed. The court ultimately dismissed the application for interim suspension.
Glaxosmithkline Pharmaceuticals v.Theodar Laboratories Private Limited
The Delhi High Court ruled in favor of Glaxosmithkline Pharmaceuticals, granting a permanent injunction against Theodar Laboratories Private Limited for infringing on its trademarked product's packaging. The court found that the defendant's carton was a 'slavish imitation' of the plaintiff's distinctive color scheme and layout, which would mislead innocent consumers purchasing animal supplements. This judgment reinforces the protection afforded to trade dress in the pharmaceutical/feed supplement sector.
Saregama India Ltd. v.Suresh Jindal And Ors.
Saregama India Ltd. sought a restraining order against Suresh Jindal And Ors., asserting that its copyrights in film songs, music, and dialogues were acquired through assignments from film producers. The core dispute revolved around whether the assignment of these rights was perpetual or time-bound. While the court initially ruled prima facie in favor of Saregama regarding the 'Katha' film, the parties subsequently reached a settlement, leading to the final disposal of the suit.
B.M. Birla Heart Research Centre v.Shree Rajmoti Industries
The dispute concerned a proposed opposition to a trade mark application (Application No. 1279800). The question before the Tribunal was whether the notice of opposition filed by Shree Rajmoti Industries on August 28, 2006, was within the prescribed statutory period, considering procedural delays and late receipt of Trade Marks Journals.
Novartis Ag v.Natco Pharma Ltd.
Natco Pharma Ltd. opposed the patent application filed by Novartis Ag for a specific crystalline form of imatinib mesylate. The Tribunal found that the invention was anticipated by prior art and did not meet the criteria for enhanced efficacy under Section 3(d). Consequently, the application was refused.
Mphasis Bfl Ltd. v.Income Tax Officer (Taxation)
The assessee, Mphasis Bfl Ltd., challenged the demand raised by the Income Tax Officer regarding non-deduction of tax at source on payments made for purchasing computer software from non-residents. The core issue was whether these payments constituted royalty under the Income Tax Act, given that the company only acquired a right to use the software, not the underlying copyright.
Indian Farmers Fertilizer Co-operative Ltd. v.Commissioner Of Central Excise
The appellant, IFFCO, challenged the demand for service tax on payments made to HALDOR TOPSOE of Denmark. The dispute centered on whether the payment was for taxable consulting engineer services or merely for the licensing of 'know-how' and technical information. The Tribunal held that since the agreement was composite, the consideration must be bifurcated, with only the portion related to technical assistance being subject to service tax.
Novartis Ag v.Hetero Drugs Limited
Novartis AG applied for a patent on the ß-crystal form of imatinib mesylate. Hetero Drugs Limited opposed the application, arguing that the invention was anticipated by prior art and did not meet the enhanced efficacy criteria under Section 3(d) of the Patents Act, 1970. The Tribunal agreed with the opposition, finding that the subject matter was a new form of a known substance without significant improvement in efficacy.
Indo Overseas Films v.Union Of India
Indo Overseas Films challenged a customs order that included a substantial royalty payment ($12,500) as part of the transaction value of an imported feature film, 'Web of Silence-AIDS'. The petitioner argued that this royalty should be excluded from the assessable value. However, the Madras High Court upheld the customs authority's decision, ruling that since the right to exploit the film was a condition precedent for importation, the associated royalties must be included in determining the duty.
Astrazeneca Uk Ltd. v.Orchid Chemicals And Pharmaceuticals
The Delhi High Court ruled in favor of the defendant, Orchid Chemicals, vacating an earlier interim injunction that had restrained them from using the trademark 'MEROMER'. The court found that while the plaintiff (Astrazeneca) claimed infringement based on deceptive similarity with 'MERONEM', the balance of convenience favored the defendant. Given that the defendant offered a cheaper alternative for the same essential drug, and considering other companies also used similar prefixes in the market, the court allowed the use of 'MEROMER' but mandated regular submission of sales accounts to safeguard the plaintiff's interests.
Gopal Glass Works Ltd. v.Iag Company Ltd. And Ors.
The petitioner sought an interim injunction against the respondents for infringing its registered design 'DIAMOND SQUARE' (No. 190336) and passing off its goods. After a complex legal history involving cancellation and restoration of the plaintiff's design, the court allowed the application partly against Defendant No. 2, restraining them from using the petitioner's design or imitation thereof.
Nitin Sethi And Anr. v.Frontier Biscuit Factory Pvt. Ltd.
This case involved a dispute over the use of the 'FRONTIER' mark, where the respondent filed a suit for permanent injunction alleging copyright and passing off infringement by the petitioners using 'OM FRONTIER'. The petitioners sought to implead the original author of the copyright under Section 61 of the Copyright Act. However, the Delhi High Court dismissed the petition, holding that the prima facie evidence provided by the respondent's certified copy from the Copyright Register established the respondent as the owner, thereby negating the need for the author's mandatory impleadment.
Wyeth Holdings Corpn. v.Controller General Of Patents, Desings ...
The petitioners challenged an order passed by the Assistant Registrar of Trade Marks, Ahmedabad. The core issue was whether Rule 50(2) of the Trade Marks Rules, 2002, which governs filing evidence in opposition, was mandatory or directory. The court held that the rule should be interpreted as 'directory' to serve the interest of justice.
Cadila Healthcare Limited v.Lupin Laboratories Ltd.
This Gujarat High Court judgment addressed a critical jurisdictional dispute regarding trademark infringement suits. Cadila Healthcare challenged the jurisdiction of the Fast Track Court, arguing that Section 134 of the Trade Marks Act mandates such cases be heard only by a District Court. The Court ultimately rejected this contention, ruling that due to the structural provisions linking Fast Track Courts and Additional Judges to the District Judge's cadre, the Fast Track Court possesses the necessary jurisdiction to try the suit.
Three-N-Products Private Ltd. v.Karnataka Soaps And Detergents Limited
The Calcutta High Court ruled in favor of Three-N-Products Private Ltd., granting an interim injunction against Karnataka Soaps And Detergents Limited (Respondent No. 1) for passing off and infringing its registered trademark 'Ayur'. The court found that the petitioner was the senior user of the mark, despite the respondent having a subsequent registration of 'Mysore Sandal Ayur Care.' This decision emphasizes the importance of establishing seniority in trade mark disputes, particularly when dealing with deceptively similar marks.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.